Tian B, Ding Z, Zong S, Yang J, Wang N, Wang T, Huang X, Hao H. Manipulation of Pharmaceutical Polymorphic Transformation Process Using Excipients.
Curr Pharm Des 2020;
26:2553-2563. [PMID:
32053064 DOI:
10.2174/1381612826666200213122302]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2019] [Accepted: 01/10/2020] [Indexed: 12/31/2022]
Abstract
BACKGROUND
In the pharmaceutical field, it is vital to ensure a consistent product containing a single solid-state form of the active pharmaceutical ingredient (API) in the drug product. However, some APIs are suffering from the risk of transformation of their target forms during processing, formulation and storage.
METHODS
The purpose of this review is to summarize the relevant category of excipients and demonstrate the availability and importance of using excipients as a key strategy to manipulate pharmaceutical polymorphic transformation.
RESULTS
The excipient effects on solvent-mediated phase transformations, solid-state transitions and amorphous crystallization are significant. Common pharmaceutical excipients including amino acids and derivatives, surfactants, and various polymers and their different manipulation effects were summarized and discussed.
CONCLUSION
Appropriate use of excipients plays a role in manipulating polymorphic transformation process of corresponding APIs, with a promising application of guaranteeing the stability and effectiveness of drug dosage forms.
Collapse